|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.775 USD | -0.54% |
|
+3.53% | +20.56% |
Mereo BioPharma Group plc reported earnings results for the half year ended June 30, 2022. For the half year, the company reported net loss was GBP 19.16 million compared to net income of GBP 12.09 million a year ago. Basic loss per share from continuing operations was GBP 0.15 compared to basic earnings per share from continuing operations of GBP 0.1 a year ago.
Diluted loss per share from continuing operations was GBP 0.15.
| 1st Jan change | Capi. | |
|---|---|---|
| +20.56% | 391M | |
| -0.25% | 103B | |
| +3.46% | 96.73B | |
| +1.31% | 21.31B | |
| -15.64% | 21.21B | |
| -6.50% | 18.79B | |
| -41.41% | 16.37B | |
| -22.23% | 13.68B | |
| +7.17% | 13.44B | |
| +24.18% | 10.98B |
MEREO BIOPHARMA GROUP PLC 
